美国FDA药品溶出方法数据库

药品通用名称	剂型	USP溶出装置	速度	溶出介质	介质体积	建议取样时间（分钟）	更新日期
Albendazole	Tablet (Chewable)	II (Paddle)	50	0.1 N HCl	900	10, 15, 20, 30 and 45	2016/03/17
Albendazole	Tablet			Refer to USP			2013/08/15
Albuterol Sulfate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Albuterol Sulfate	Tablet (Extended Release)	II (Paddle)	50	0.1 N HCl	900	1, 2, 4, 6, 9 and 12 hours	2007/04/09
Alectinib HCl	Capsule	II (Paddle) with sinker	100	pH 1.2, Simulated Gastric Fluid without pepsin, containing 4 % Triton X-100 [polyoxyethylene[10]octylphenyl ether]	900	10, 20, 30, 45, 60, 75 and 90	2016/03/17
Alendronate Sodium	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Alendronate Sodium/Cholecalciferol	Tablet			Develop a dissolution method			2023/09/15
Alfuzosin HCl	Tablet (Extended Release)	II (Paddle)	100	0.01 N HCl	900	1, 2, 12, 20 hours	2007/06/18
Aliskiren Hemifumarate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Aliskiren Hemifumarate	Capsule (pellet)	I (Basket)	100	0.01 M HCl (degas)	500	5, 10, 15, 20, 30 and 45	2018/02/08
Aliskiren Hemifumarate/Amlodipine Besylate	Tablet	I (Basket)	100	0.01 N HCl, pH 2.0	500	10, 15, 20, 30 and 45	2012/06/07
Aliskiren Hemifumarate/Amlodipine Besylate/Hydrochlorothiazide	Tablet	I (Basket)	100	0.01 N HCl	900	10, 15, 20, 30 and 45	2012/06/07
Aliskiren Hemifumarate/Hydrochlorothiazide	Tablet	I (Basket)	100	0.1 N HCl	900	10, 15, 20, 30 and 45	2009/10/08
Aliskiren Hemifumarate/Valsartan	Tablet	I (Basket)	100	Phosphate Buffer, pH 6.8	1000	5, 10, 15, 20, 30 and 45	2010/12/23
Allopurinol	Tablet			Refer to USP			2007/07/25
Almotriptan Malate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Alogliptin Benzoate	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Alogliptin Benzoate/ Metformin HCl	Tablet	II (Paddle)	50	0.01 N HCl	900	5, 10, 15, 20 and 30	2015/11/19
Alosetron HCl	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02
Alprazolam	Tablet			Refer to FDA's Dissolution Guidance, 2018			2020/07/02